384 related articles for article (PubMed ID: 29170127)
21. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
Tan X; Jiang L; Wu X; Feng W; Lin Q
Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
[TBL] [Abstract][Full Text] [Related]
22. MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.
Shan N; Shen L; Wang J; He D; Duan C
Biochem Biophys Res Commun; 2015 Jan; 456(1):385-91. PubMed ID: 25475731
[TBL] [Abstract][Full Text] [Related]
23. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
24. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
25. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
Liao XH; Xie Z; Guan CN
Neoplasma; 2018 Sep; 65(5):673-682. PubMed ID: 30249107
[TBL] [Abstract][Full Text] [Related]
26. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of Calbindin 1 by miR-454-3p Suppresses Cell Proliferation in Nonsmall Cell Lung Cancer In Vitro.
Jin C; Lin T; Shan L
Cancer Biother Radiopharm; 2019 Mar; 34(2):119-127. PubMed ID: 30638403
[TBL] [Abstract][Full Text] [Related]
28. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
[TBL] [Abstract][Full Text] [Related]
29. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
Li J; Feng Q; Wei X; Yu Y
Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057
[TBL] [Abstract][Full Text] [Related]
31. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
Hu C; Zou Y; Jing LL
J Biosci; 2020; 45():. PubMed ID: 32345774
[TBL] [Abstract][Full Text] [Related]
32. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
33. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
Liu B; Li J; Zheng M; Ge J; Li J; Yu P
Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
[TBL] [Abstract][Full Text] [Related]
34. LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1.
Wei S; Liu J; Li X; Liu X
BMC Pulm Med; 2020 Mar; 20(1):78. PubMed ID: 32228546
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1.
Chen G; Hu J; Huang Z; Yang L; Chen M
Biochem Biophys Res Commun; 2016 May; 473(4):1144-1151. PubMed ID: 27063799
[TBL] [Abstract][Full Text] [Related]
36. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
37. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
[TBL] [Abstract][Full Text] [Related]
38. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
[TBL] [Abstract][Full Text] [Related]
39. miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2.
Gao P; Wang H; Yu J; Zhang J; Yang Z; Liu M; Niu Y; Wei X; Wang W; Li H; Wang Y; Sun G
PLoS Genet; 2018 Dec; 14(12):e1007790. PubMed ID: 30557355
[TBL] [Abstract][Full Text] [Related]
40. miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC.
Feng QQ; Dong ZQ; Zhou Y; Zhang H; Long C
Bratisl Lek Listy; 2018; 119(1):60-65. PubMed ID: 29405733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
